165 related articles for article (PubMed ID: 37740740)
1. Face to Face: deciphering facial involvement in inclusion body myositis.
Fortanier E; Delmont E; Kouton L; Corazza G; Grapperon AM; Verschueren A; Attarian S; Salort-Campana E
J Neurol; 2024 Jan; 271(1):410-418. PubMed ID: 37740740
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the face in facioscapulohumeral muscular dystrophy.
Loonen TGJ; Horlings CGC; Vincenten SCC; Beurskens CHG; Knuijt S; Padberg GWAM; Statland JM; Voermans NC; Maal TJJ; van Engelen BGM; Mul K
J Neurol; 2021 Apr; 268(4):1342-1350. PubMed ID: 33113021
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of the patient-reported "Facial Function Scale" for facioscapulohumeral muscular dystrophy.
Mul K; Wijayanto F; Loonen TGJ; Groot P; Vincenten SCC; Knuijt S; Groothuis JT; Maal TJJ; Heskes T; Voermans NC; Engelen BGMV
Disabil Rehabil; 2023 May; 45(9):1530-1535. PubMed ID: 35575310
[TBL] [Abstract][Full Text] [Related]
4. Inclusion-body myositis presenting with facial diplegia.
Ghosh PS; Laughlin RS; Engel AG
Muscle Nerve; 2014 Feb; 49(2):287-9. PubMed ID: 24038039
[TBL] [Abstract][Full Text] [Related]
5. Atypical progression of motor symptoms in facio-scapulo-humeral dystrophy: clinical worsening or overlap?
Calisi D; De Rosa MA; Russo M; Sensi SL
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37247956
[TBL] [Abstract][Full Text] [Related]
6. Correlation Between Quantitative MRI and Muscle Histopathology in Muscle Biopsies from Healthy Controls and Patients with IBM, FSHD and OPMD.
Lassche S; Küsters B; Heerschap A; Schyns MVP; Ottenheijm CAC; Voermans NC; van Engelen BGM
J Neuromuscul Dis; 2020; 7(4):495-504. PubMed ID: 32925090
[TBL] [Abstract][Full Text] [Related]
7. Facing facial weakness: psychosocial outcomes of facial weakness and reduced facial function in facioscapulohumeral muscular dystrophy.
van de Geest-Buit WA; Rasing NB; Mul K; Deenen JCW; Vincenten SCC; Siemann I; Lanser A; Groothuis JT; van Engelen BG; Custers JAE; Voermans NC
Disabil Rehabil; 2023 Jul; 45(15):2507-2516. PubMed ID: 35815498
[TBL] [Abstract][Full Text] [Related]
8. Effects of weakness of orofacial muscles on swallowing and communication in FSHD.
Mul K; Berggren KN; Sills MY; McCalley A; van Engelen BGM; Johnson NE; Statland JM
Neurology; 2019 Feb; 92(9):e957-e963. PubMed ID: 30804066
[TBL] [Abstract][Full Text] [Related]
9. Atypical presentations of inclusion body myositis: Clinical characteristics and long-term outcomes.
Alamr M; Pinto MV; Naddaf E
Muscle Nerve; 2022 Dec; 66(6):686-693. PubMed ID: 36052422
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic spectrum of inclusion body myositis.
Roy B; Dimachkie MM; Naddaf E
Clin Exp Rheumatol; 2024 Feb; 42(2):445-453. PubMed ID: 38436356
[TBL] [Abstract][Full Text] [Related]
11. Experiences of patients with facioscapulohumeral dystrophy with facial weakness: a qualitative study.
Sezer S; Cup EHC; Roets-Merken LM; Lanser A; Siemann I; Weikamp JG; Mul K; van Engelen BG; Satink T; Voermans NC
Disabil Rehabil; 2022 Nov; 44(22):6775-6782. PubMed ID: 34529524
[TBL] [Abstract][Full Text] [Related]
12. Speech and swallowing characteristics in patients with facioscapulohumeral muscular dystrophy.
Santos VBD; Saute JAM; Jacinto-Scudeiro LA; Ayres A; Rech RS; Oliveira AA; Olchik MR
Arq Neuropsiquiatr; 2022 Apr; 80(4):368-374. PubMed ID: 35195226
[TBL] [Abstract][Full Text] [Related]
13. What's in a name? The clinical features of facioscapulohumeral muscular dystrophy.
Mul K; Lassche S; Voermans NC; Padberg GW; Horlings CG; van Engelen BG
Pract Neurol; 2016 Jun; 16(3):201-7. PubMed ID: 26862222
[TBL] [Abstract][Full Text] [Related]
14. A pediatric case report and literature review of facioscapulohumeral muscular dystrophy type1.
Xiao T; Yang H; Gan S; Wu L
Medicine (Baltimore); 2021 Nov; 100(47):e27907. PubMed ID: 34964760
[TBL] [Abstract][Full Text] [Related]
15. Updating the Clinical Picture of Facioscapulohumeral Muscular Dystrophy: Ramifications for Drug Development With Potential Solutions.
Huml RA; Uspenskaya-Cadoz O; Dawson J; Slifer Z
Ther Innov Regul Sci; 2020 Jan; 54(1):144-150. PubMed ID: 32008231
[TBL] [Abstract][Full Text] [Related]
16. Inclusion body myositis with early onset: a population-based study.
Lindgren U; Hedberg-Oldfors C; Pullerits R; Lindberg C; Oldfors A
J Neurol; 2023 Nov; 270(11):5483-5492. PubMed ID: 37498322
[TBL] [Abstract][Full Text] [Related]
17. Treatment Approaches for Altered Facial Expression: A Systematic Review in Facioscapulohumeral Muscular Dystrophy and Other Neurological Diseases.
Rasing NB; van de Geest-Buit WA; Chan OYA; Mul K; Lanser A; van Engelen BGM; Erasmus CE; Fischer AH; Ingels KJAO; Post B; Siemann I; Groothuis JT; Voermans NC
J Neuromuscul Dis; 2024; 11(3):535-565. PubMed ID: 38517799
[TBL] [Abstract][Full Text] [Related]
18. Cricopharyngeal bar on videofluoroscopy: high specificity for inclusion body myositis.
Taira K; Yamamoto T; Mori-Yoshimura M; Sajima K; Takizawa H; Shinmi J; Oya Y; Nishino I; Takahashi Y
J Neurol; 2021 Mar; 268(3):1016-1024. PubMed ID: 32980980
[TBL] [Abstract][Full Text] [Related]
19. Clinical Muscle Testing Compared with Whole-Body Magnetic Resonance Imaging in Facio-scapulo-humeral Muscular Dystrophy.
Regula JU; Jestaedt L; Jende F; Bartsch A; Meinck HM; Weber MA
Clin Neuroradiol; 2016 Dec; 26(4):445-455. PubMed ID: 25860436
[TBL] [Abstract][Full Text] [Related]
20. Facioscapulohumeral muscular dystrophy: a radiologic and manometric study of the pharynx and esophagus.
Stübgen JP
Dysphagia; 2008 Dec; 23(4):341-7. PubMed ID: 18259705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
